Fresenius Medical Care Stock Return On Asset
| FMCQF Stock | USD 49.25 0.13 0.26% |
Fundamental analysis of Fresenius Medical allows traders to better anticipate movements in Fresenius Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Fresenius |
Fresenius Medical Care Company Return On Asset Analysis
Fresenius Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Fresenius Medical Return On Asset | 0.0253 |
Most of Fresenius Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Fresenius Medical Care has a Return On Asset of 0.0253. This is 100.29% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The return on asset for all United States stocks is 118.07% lower than that of the firm.
Fresenius Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in return on asset category among its peers.
Fresenius Fundamentals
| Return On Equity | 0.0666 | |||
| Return On Asset | 0.0253 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 22.64 B | |||
| Shares Outstanding | 293.41 M | |||
| Shares Owned By Insiders | 32.16 % | |||
| Shares Owned By Institutions | 38.34 % | |||
| Price To Earning | 11.60 X | |||
| Price To Book | 0.58 X | |||
| Price To Sales | 0.49 X | |||
| Revenue | 17.62 B | |||
| Gross Profit | 5.08 B | |||
| EBITDA | 1.93 B | |||
| Net Income | 969.31 M | |||
| Cash And Equivalents | 1.11 B | |||
| Cash Per Share | 3.07 X | |||
| Total Debt | 6.65 B | |||
| Debt To Equity | 0.82 % | |||
| Current Ratio | 1.34 X | |||
| Book Value Per Share | 41.54 X | |||
| Cash Flow From Operations | 2.49 B | |||
| Earnings Per Share | 2.79 X | |||
| Price To Earnings To Growth | 1.04 X | |||
| Number Of Employees | 122.76 K | |||
| Beta | 0.9 | |||
| Market Capitalization | 11.24 B | |||
| Total Asset | 34.37 B | |||
| Retained Earnings | 8.45 B | |||
| Working Capital | 1.96 B | |||
| Current Asset | 7.22 B | |||
| Current Liabilities | 5.25 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 1.30 % | |||
| Net Asset | 34.37 B | |||
| Last Dividend Paid | 1.35 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Fresenius Pink Sheet
When determining whether Fresenius Medical Care is a strong investment it is important to analyze Fresenius Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Fresenius Medical's future performance. For an informed investment choice regarding Fresenius Pink Sheet, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.